Evaluation of Virtual Reality to Save Morphinic in the Treatment of Vaso-occlusive Seizures of Sickle Cell Patients Consulting in the Emergency Room

Study point of contact

Evelyne DUBREUCQ, MD
06 52 09 64 28
[email protected]
Hélène GOULET, MD
06 62 70 91 75
[email protected]

Locations

1 France site

Age

> 18 Years

Phase

N/A

Study type

Interventional

Gender

All

Interventions

Device

Other

Compensation

Unknown

About the study

The management of pain in the emergency department is a major issue, especially for sickle
cell patients who regularly consult for vaso-occlusive seizure (VOS). The place of virtual
reality remains to be defined in a busy environment, in which the permanence of care
generates a significant turn over of medical and paramedical personnel.

With Its immersive nature, allowing the patient to detach from his immediate environment,
wich is often stressful for patients, we can hope that in multimodal management, Virtual
Reality (VR) can contribute to a faster reduction in pain with lower doses of morphine, but
so far we have no data.

Our pilot study aims to assess the effectiveness, feasibility and tolerance of adding virtual
reality to the management of VOS in sickle cell patients in the ER.

participation requirements

– Age ≥ 18 years

– sickle cell patient consulting in the emergency room for VOS

– Signature free and informed consent

participation restrictions

– Consultation in the ER for the same reason in the 14 days prior to inclusion (same
episode)

– Emergency room consultation more than 12 times in the previous year

– Nausea and vomiting at the time of inclusion

– History of epilepsy

– A visually impaired or hard of hearing patient

– Pregnant patient

– Previous inclusion in the study

Locations

  • Paris, France, HOPITAL TENON Service des urgences, 75020

More info

View on ClinicalTrials.gov
Site is under construction